World's Best Scientists 2026 revealed!
Nicolas Chomont

Nicolas Chomont

D-Index & Metrics

Immunology

D-Index
71
Citations
22145
World Ranking
2291
National Ranking
49

Nicolas Chomont publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Nicolas Chomont sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 271 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Nicolas Chomont D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Nicolas Chomont sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Nicolas Chomont is affiliated with the University of Montreal in Canada and contributes extensively to the fields of immunology and microbiology, with a significant focus on medicine. Their research encompasses virology, immunology, infectious diseases, epidemiology, and emergency medicine, addressing complex aspects of immune cell function and infectious disease mechanisms.

Their main topics of work include HIV research and treatment, immune cell function and interaction, HIV/AIDS research and interventions, T-cell and B-cell immunology, HIV-related health complications and treatments, HIV/AIDS drug development and treatment, and cytomegalovirus and herpesvirus research. This wide array highlights a specialization in understanding viral infections and immune responses, particularly related to HIV.

Frequent publication venues for Nicolas Chomont's work comprise bioRxiv (Cold Spring Harbor Laboratory), Journal of Virus Eradication, Journal of Virology, EBioMedicine, and Nature Communications. These platforms indicate an active engagement with both pre-publication and peer-reviewed scientific literature in the field of virology and immunology.

Their recent published papers include:

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021 (2021, Nature Medicine)
  • The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies (2020, Cell Host & Microbe)
  • Recommendations for measuring HIV reservoir size in cure-directed clinical trials (2020, Nature Medicine)
  • Single-cell TCR sequencing reveals phenotypically diverse clonally expanded cells harboring inducible HIV proviruses during ART (2020, Nature Communications)
  • Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection (2020, Science Translational Medicine)

Their work frequently involves collaboration with other researchers, including Amélie Pagliuzza, Rémi Fromentin, Jean-Pierre Routy, Daniel E. Kaufmann, and Petronela Ancuța. These frequent coauthors contribute to a robust collaborative network in HIV and immunology research.

Best Publications

  • HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

    Nicolas Chomont;Mohamed El-Far;Petronela Ancuta;Lydie Trautmann

  • Upregulation of PD-1 expression on HIV-specific CD8 + T cells leads to reversible immune dysfunction

    Lydie Trautmann;Loury Janbazian;Loury Janbazian;Nicolas Chomont;Elias A. Said

  • Towards an HIV cure: a global scientific strategy

    Steven G Deeks;Brigitte Autran;Ben Berkhout;Monsef Benkirane

  • The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.

    Ole S. Søgaard;Mette E. Graversen;Steffen Leth;Rikke Olesen

  • Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

    Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim

  • Immune activation and HIV persistence: implications for curative approaches to HIV infection

    Nichole R. Klatt;Nicolas Chomont;Daniel C. Douek;Steven G. Deeks

  • Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

    Rebecca M. Lynch;Eli Boritz;Emily E. Coates;Adam DeZure

  • International AIDS Society global scientific strategy: towards an HIV cure 2016

    Steven G Deeks;Sharon R Lewin;Anna Laura Ross;Jintanat Ananworanich

  • CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART

    Rémi Fromentin;Wendy Bakeman;Mariam B. Lawani;Gabriela Khoury;Gabriela Khoury

  • Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants

    Bonnie Hiener;Bethany A. Horsburgh;John-Sebastian Eden;Kirston Barton

  • Peripheral Blood CCR4 + CCR6 + and CXCR3 + CCR6 + CD4 + T Cells Are Highly Permissive to HIV-1 Infection

    Annie Gosselin;Patricia Monteiro;Nicolas Chomont;Felipe Diaz-Griffero

  • Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection.

    Jintanat Ananworanich;Alexandra Schuetz;Claire Vandergeeten;Irini Sereti

  • Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.

    Steven G. Deeks;Nancie Archin;Paula Cannon;Simon Collins

  • Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection.

    Donn J. Colby;Lydie Trautmann;Lydie Trautmann;Suteeraporn Pinyakorn;Suteeraporn Pinyakorn;Louise Leyre

  • HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals

    Didier Trono;Carine Van Lint;Christine Rouzioux;Eric Verdin

  • The Biology of the HIV-1 Latent Reservoir and Implications for Cure Strategies.

    Lillian B. Cohn;Nicolas Chomont;Steven G. Deeks

  • Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.

    Irini Sereti;Shelly J. Krebs;Nittaya Phanuphak;James L. Fletcher

  • A Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected Individuals

    Francesco Andrea Procopio;Rémi Fromentin;Deanna A. Kulpa;Jessica H. Brehm

  • Cross-Clade Ultrasensitive PCR-Based Assays To Measure HIV Persistence in Large-Cohort Studies

    Claire Vandergeeten;Rémi Fromentin;Esther Merlini;Mariam B. Lawani

  • Interleukin-7 promotes HIV persistence during antiretroviral therapy

    Claire Vandergeeten;Rémi Fromentin;Sandrina DaFonseca;Mariam B. Lawani

  • HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART

    Jintanat Ananworanich;Jintanat Ananworanich;Nicolas Chomont;Leigh Ann Eller;Leigh Ann Eller;Eugene Kroon

  • Corrigendum: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

    L. Trautmann;L. Janbazian;N. Chomont;E. A. Said

Frequent Co-Authors

Jean-Pierre Routy
Jean-Pierre Routy McGill University Health Centre
Rémi Fromentin
Rémi Fromentin University of Montreal
Jintanat Ananworanich
Jintanat Ananworanich Moderna Therapeutics (United States)
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Steven G. Deeks
Steven G. Deeks University of California, San Francisco
Merlin L. Robb
Merlin L. Robb Walter Reed Army Institute of Research
Petronela Ancuta
Petronela Ancuta University of Montreal
Laurent Bélec
Laurent Bélec Université Paris Cité
Nelson L. Michael
Nelson L. Michael Walter Reed Army Institute of Research
Rafick P. Sekaly
Rafick P. Sekaly Emory University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing immunology in the USA opens doors to diverse healthcare careers, including advanced nursing roles. For those interested in specializing, programs like the cheapest psychiatric nurse practitioner programs offer affordable pathways to gain essential expertise and certifications without a hefty price tag.

Nurse practitioners, especially those with Doctor of Nursing Practice (DNP) degrees, can expect competitive salaries that vary by location. Understanding how much do dnps make is vital for planning long-term career goals and deciding where to practice.

For nurses aiming to broaden their scope, transitioning from family nurse practitioner to a more specialized field is achievable. The guide on fnp to acute care certification highlights the necessary steps to make this shift smoothly, opening up new clinical opportunities in acute care settings.

Accelerated education options also support faster career advancement. Exploring the accelerated nurse practitioner program can be a strategic move for immunology students eager to enter the workforce quickly with specialized skills.

Best Scientists Citing Nicolas Chomont

Trending Scientists

Recently Published Articles